S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item

Maxpro Capital Acquisition (JMAC) Competitors

$0.56
0.00 (0.00%)
(As of 04/12/2024 ET)

JMAC vs. DMAQ, EFHT, HAIA, LBBB, LAAA, NIVF, EGOX, ATAK, AITR, and OLIT

Should you be buying Maxpro Capital Acquisition stock or one of its competitors? The main competitors of Maxpro Capital Acquisition include Deep Medicine Acquisition (DMAQ), EF Hutton Acquisition Co. I (EFHT), Healthcare AI Acquisition (HAIA), Lakeshore Acquisition II (LBBB), Lakeshore Acquisition I (LAAA), NewGenIvf Group (NIVF), Next.e.GO (EGOX), Aurora Technology Acquisition (ATAK), AI Transportation Acquisition (AITR), and OmniLit Acquisition (OLIT). These companies are all part of the "holding & other investment offices" industry.

Maxpro Capital Acquisition vs.

Deep Medicine Acquisition (NASDAQ:DMAQ) and Maxpro Capital Acquisition (NASDAQ:JMAC) are both small-cap unclassified companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, community ranking, media sentiment, earnings, institutional ownership, analyst recommendations, risk, valuation and profitability.

Deep Medicine Acquisition and Maxpro Capital Acquisition both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Deep Medicine AcquisitionN/AN/A
Maxpro Capital AcquisitionN/AN/A

Company Net Margins Return on Equity Return on Assets
Deep Medicine AcquisitionN/A N/A N/A
Maxpro Capital Acquisition N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Deep Medicine Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Maxpro Capital Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

In the previous week, Maxpro Capital Acquisition's average media sentiment score of 0.00 equaled Deep Medicine Acquisition'saverage media sentiment score.

Company Overall Sentiment
Deep Medicine Acquisition Neutral
Maxpro Capital Acquisition Neutral

18.4% of Deep Medicine Acquisition shares are held by institutional investors. Comparatively, 73.2% of Maxpro Capital Acquisition shares are held by institutional investors. 1.7% of Deep Medicine Acquisition shares are held by insiders. Comparatively, 19.3% of Maxpro Capital Acquisition shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Deep Medicine Acquisition has a beta of 0.02, meaning that its share price is 98% less volatile than the S&P 500. Comparatively, Maxpro Capital Acquisition has a beta of 0.01, meaning that its share price is 99% less volatile than the S&P 500.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Deep Medicine AcquisitionN/AN/AN/AN/AN/A
Maxpro Capital AcquisitionN/AN/AN/AN/AN/A

Summary

Maxpro Capital Acquisition beats Deep Medicine Acquisition on 2 of the 3 factors compared between the two stocks.

Get Maxpro Capital Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for JMAC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding JMAC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

JMAC vs. The Competition

MetricMaxpro Capital AcquisitionHolding Offices IndustryUnclassified SectorNASDAQ Exchange
Market Cap$7.51M$316.88M$132.99M$7.66B
Dividend YieldN/A8.54%N/A3.93%
P/E RatioN/A4.034.4115.74
Price / SalesN/A9.100.14103.23
Price / CashN/A53.9066.5130.98
Price / BookN/A94.85369.274.29
Net IncomeN/A-$7.85M$5.20M$214.57M
7 Day Performance-2.90%-0.37%0.70%-2.30%
1 Month Performance-4.20%10.11%11.56%-0.06%
1 Year Performance-91.89%2.20%1.56%8.81%

Maxpro Capital Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DMAQ
Deep Medicine Acquisition
0 of 5 stars
$1.81
+30.2%
N/AN/A$7.89MN/A0.00N/AHigh Trading Volume
EFHT
EF Hutton Acquisition Co. I
0 of 5 stars
$1.03
+7.3%
N/A-86.3%$6.82MN/A0.00N/ANews Coverage
Gap Up
HAIA
Healthcare AI Acquisition
0 of 5 stars
$11.07
flat
N/A+6.5%$6.55MN/A0.002,021Short Interest ↑
LBBB
Lakeshore Acquisition II
0 of 5 stars
$3.00
-36.7%
N/AN/A$10.77MN/A0.00N/AGap Down
High Trading Volume
LAAA
Lakeshore Acquisition I
0 of 5 stars
$0.54
-5.3%
N/A-89.6%$3.84MN/A0.002,021Gap Down
NIVF
NewGenIvf Group
0 of 5 stars
$0.98
+6.5%
N/AN/A$3.66MN/A0.00N/AGap Down
EGOX
Next.e.GO
0 of 5 stars
$0.04
flat
N/AN/A$3.10MN/A0.00N/AShort Interest ↑
News Coverage
Gap Down
High Trading Volume
ATAK
Aurora Technology Acquisition
0 of 5 stars
$1.13
+2.7%
N/A-87.7%$12.05MN/A0.00N/A
AITR
AI Transportation Acquisition
0 of 5 stars
$10.28
-0.1%
N/AN/A$21.18MN/A0.00N/A
OLIT
OmniLit Acquisition
0 of 5 stars
$3.63
+6.8%
N/A-66.9%$22.29MN/A0.002,021News Coverage
Gap Down

Related Companies and Tools

This page (NASDAQ:JMAC) was last updated on 4/14/2024 by MarketBeat.com Staff

From Our Partners